|
Peru
|
8.3 Hormones and Antihormones
|
No observations
|
|
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health.
|
Aromatase Inhibitors
|
No observations
|
|
Costa Rica. Caja Costarricense de Seguro Social. 2019
|
41. Antineoplásicos y agentes inmunomoduladores
|
No observations
|
|
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015
|
08.06 HORMONE ANTAGONISTS
|
No observations
|
|
Mexico. Cuadro Basico de Medicamentos - 2017
|
17. ONCOLOGIA
|
No observations
|
|
Paraguay. Lista de Medicamentos Esenciales. 2009
|
02. TERAPIA ENDÓCRINA
|
No observations
|
|
WHO Model List of Essential Medicines (2021)
|
8.2.4. Hormones and antihormones
|
No observations
|
|
Guyana. Essential Medicines List. 2020-2021
|
9.02.05. Hormone Antagonists
|
No observations
|
|
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021
|
10:00 Anti-neoplastic agents
|
No observations
|
|
Suriname. NGK-C-011
|
8.4 Cytotoxic Agents: Hormones and Anti-Hormones
|
No observations
|
|
Haiti. National List of Essential Medicines
|
08.03 Hormones and Antihormones
|
No observations
|
|
Barbados. Barbados National Drug Formulary (BNDF)
|
10.0 Antineoplastics
|
No observations
|
|
Bahamas. Drug Formulary
|
10. ANTINEOPLASTIC AND RELATED AGENTS
|
No observations
|
